Skip to main content
BeOne Medicines Ltd. (HKG:6160)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
155.90
+4.60 (3.04%)
Jun 4, 2025, 4:08 PM HKT

BeOne Medicines Revenue

BeOne Medicines had revenue of 8.05B CNY in the quarter ending March 31, 2025, with 48.28% growth. This brings the company's revenue in the last twelve months to 30.34B, up 52.09% year-over-year. In the year 2024, BeOne Medicines had annual revenue of 27.81B with 59.51% growth.

Revenue (ttm)
30.34B CNY
Revenue Growth
+52.09%
P/S Ratio
7.20
Revenue / Employee
2.76M CNY
Employees
11,000
Market Cap
234.22B HKD

Revenue Chart

* This company reports financials in CNY.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202427.81B10.38B59.51%
Dec 31, 202317.43B7.67B78.53%
Dec 31, 20229.77B2.29B30.69%
Dec 31, 20217.47B5.46B270.56%
Dec 31, 20202.02B-965.08M-32.37%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Hansoh Pharmaceutical Group Company 13.05B
JD Health International 61.89B
Innovent Biologics 10.03B
WuXi Biologics 19.87B
CSPC Pharmaceutical Group 28.99B
Sino Biopharmaceutical 30.72B
Sichuan Kelun-Biotech Biopharmaceutical 2.06B
Alibaba Health Information Technology 32.81B
Revenue Rankings

BeOne Medicines News

More News